Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014

Allergies 2014

09 Jul 2014 - 10 Jul 2014 - London, UK

Bookmark and Share

Analyse industry developments and the future of allergy therapeutics

The launch event for Allergies is here and will be taking place on 9th July and 10th July 2014 in Central London. The market for Allergies is expected to reach $14.7 billion by 2015. As companies look to develop different compounds and antibodies to treat allergies, this event will mark the path forward in terms of allergies within personalised medicines and beyond.

We have worked in partnership with an expert advisory board which includes KOLs from Imperial College London, Swecure AB and GSK, to put together an exciting conference agenda.

The programme will examine key areas such as novel approaches in the treatment of allergy, therapeutic advances, allergic pathophysiology, current update on food allergies, the future of allergen-specific immunotherapy and challenges, allergy prevention, diagnosis and drug development plus much more. 

Reasons to Attend:

  • Key case study presentation from GSK on new therapeutic tools for allergies
  • Clinicians' perspective – advances in allergy diagnostics featuring Royal Free Hospital and Imperial College London
  • Allergy specialists – Dr Scadding and Dr Church present on new research and findings
  • Exclusive case study on the success of peanut allergy trials
  • Evaluate new breakthroughs in allergy treatment and gain understanding into guidance on development novel therapeutics
  • Analyse current and novel approaches of allergen-specific immunotherapy 

Key Speakers Include:

  • Daphne Tsitoura, Senior Medical Director, Clinical Drug Development / Discovery Medicine, GSK
  • Professor Alf Lindberg, Chief Scientific Director, Swecure AB
  • Dr Rainer Henning, CEO, Biomay AG
  • Dr Donna Finch, Principal Scientist, MedImmune
  • Dr Glenis Scadding, Honorary Consultant Allergist & Rhinologist, Royal National Throat, Nose and Ear Hospital
  • Calman Prussin, Principal Investigator, National Institute of Allergy and Infectious Diseases(NIAID)
  • Professor Rudolf Valenta, Professor for Allergology, Medical University of Vienna

To register online or to download a brochure visit

Alternatively contact John Collins on +44 (0)20 7827 6734 or email

Further information
Scientific News
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
Developing Drug Resistance may be a Matter of Diversity for Tuberculosis
Researchers have probed the bacteria that causes tuberculosis, Mycobacterium tuberculosis, to learn more about how individual bacterial cells change and adapt while in the human body.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
Essential Component of Antiviral Defense Identified
Infectious disease researchers at the University of Georgia have identified a signaling protein critical for host defense against influenza infection.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Is Allergy the Price We Pay for Our Immunity to Parasites?
New findings help demonstrate the evolutionary basis for allergy.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
Mucus – the First Line of Defence
Researchers reveal the important role of mucus in building a good defence against invaders.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos